Study brain-targeted radiation for limited brain metastases
Part of Brain & nervous system, Cancer clinical trials.
This study looks at people with a small number of brain metastases who are treated with a focused, staged form of radiation after surgery or to treat the cancer. It may help doctors better understand how well this approach works and who benefits most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that is not blood cancer, confirmed by pathology (biopsy/surgery results).
- You are being referred for focused, staged radiation to the brain (hypofractionated stereotactic radiotherapy).
- Your general functioning is fair to good: ECOG score 0–2, or a Karnofsky score of at least 70.
- You have up to 3 brain metastases, and each one is no larger than 4 cm on the pre-treatment MRI.
- Your MRI does not show tumors very close to the hippocampus (within 5 mm).
- You have not had prior brain/head stereotactic radiation (including radiosurgery).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving focused radiation for brain metastases: before surgery or after surgery. It aims to see which timing works better to control tumors while keeping you safe.
This trial compares giving stereotactic radiosurgery (focused radiation) before versus after surgery to remove brain metastases. It aims to see which timing may help control the cancer while possibly reducing side effects on thinking and memory.
This study compares giving focused, high-dose radiation before surgery versus after surgery for people with large brain metastases. The goal is to see which timing works best to control the tumors and help neurological outcomes.
This study tests a new type of radiation therapy (iHD-SRT) for people with brain metastases. It aims to see if this approach is safe and effective for treating tumors that have spread to the brain.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This Phase 1 study tests a form of focused radiation given in stages to shrink larger brain metastases. It may help people whose tumors are in the brain but not suited to whole-brain radiation alone, while also checking safety and how well the treatment can be delivered.
Hear when a new Brain Metastases, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.